Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study

James Krueger; Richard G. Langley; Simon Nigen; Torben Kasparek; Gabriele Di Comite; Christine Elke Ortmann; Sandra Garcet; Frank Kolbinger; Kristian Reich

doi:10.1111/exd.14828

Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study

James Krueger, Richard G. Langley, Simon Nigen, Torben Kasparek, Gabriele Di Comite, Christine Elke Ortmann, Sandra Garcet, Frank Kolbinger, Kristian Reich

科研成果: 期刊稿件 › 文章 › 同行评审

3 引用（Scopus）

源语言	英语
页（从-至）	1834-1847
页数	14
期刊	Experimental Dermatology
卷	32
期	10
DOI	https://doi.org/10.1111/exd.14828
出版状态	已出版 - 10月 2023
已对外发布	是

!!!ASJC Scopus Subject Areas

生物化学
分子生物学
皮肤医学

访问文件

10.1111/exd.14828

其它文件与链接

引用此

@article{452132bc38204d47931f934b2e82482f,

title = "Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study",

keywords = "guselkumab, IL-17, resistant psoriatic plaque, secukinumab, ustekinumab",

author = "James Krueger and Langley, {Richard G.} and Simon Nigen and Torben Kasparek and {Di Comite}, Gabriele and Ortmann, {Christine Elke} and Sandra Garcet and Frank Kolbinger and Kristian Reich",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.",

year = "2023",

month = oct,

doi = "10.1111/exd.14828",

language = "English",

volume = "32",

pages = "1834--1847",

journal = "Experimental Dermatology",

issn = "0906-6705",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques

T2 - The ARROW study

AU - Krueger, James

AU - Langley, Richard G.

AU - Nigen, Simon

AU - Kasparek, Torben

AU - Di Comite, Gabriele

AU - Ortmann, Christine Elke

AU - Garcet, Sandra

AU - Kolbinger, Frank

AU - Reich, Kristian

PY - 2023/10

Y1 - 2023/10

KW - guselkumab

KW - IL-17

KW - resistant psoriatic plaque

KW - secukinumab

KW - ustekinumab

UR - http://www.scopus.com/inward/record.url?scp=85161362630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85161362630&partnerID=8YFLogxK

U2 - 10.1111/exd.14828

DO - 10.1111/exd.14828

M3 - Article

C2 - 37272375

AN - SCOPUS:85161362630

SN - 0906-6705

VL - 32

SP - 1834

EP - 1847

JO - Experimental Dermatology

JF - Experimental Dermatology

IS - 10

ER -

Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此